MGUS

Clinical Trials

We help myeloma patients find, understand and connect with their clinical trial options at centers around the US. Create your account today to start your personalized clinical trial report.

Create My Account

We believe...

The path towards newer, better therapies and one day a cure for myeloma, is through clinical trials. Yet, less than 1 out of every 10 myeloma patients will ever participate in a clinical trial. We're on a mission to change this.

As caregivers, we know how difficult it can be to find and understand your clinical trial options. It's why we started SparkCures.

Call us today and we can help answer any questions that you may have. You can also create your free account to get your personalized report.

Call or text us today

(888) 828-2206

Create My Account

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in P...
EXCALIBER RRMM
View Trial
Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Re...
SUCCESSOR-2
View Trial
Verified
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...
MONUMENTAL-3
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab VS Lenalidomide in Participants with Newly Diagnosed Multiple Myeloma Who Have H...
MAGNETISMM-7
View Trial
Verified
Phase 3 Clinical Trial Comparing Iberdomide VS Lenalidomide as Maintenance Therapy Following Autologous Stem Cell Transplant in Participants with Newly Diagn...
EXCALIBER-MAINTENANCE
View Trial
Verified
Phase 3 Clinical Trial Comparing a Study Medication Alone Versus Pomalidomide, Bortezomib, Dexamethasone or Carfilzomib and Dexamethasone in Patients with Re...
MAJESTEC-9
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...
MAGNETISMM-32
View Trial
Verified
A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...
LINKER-MM3
View Trial
Verified
Phase 2, Open-Label Study Evaluating the Use of an Investigational CAR-T Cell therapy in Participants with Multiple Myeloma
CARTITUDE-2
View Trial
Verified
Phase 2 Study of BMS-986393, a GPRC5D-directed CART-Cell Therapy, in Participants with Relapsed or Refractory Multiple Myeloma
QUINTESSENTIAL
View Trial
Verified
A Phase 2, Open-label, Randomized Study to Evaluate Prophylactic Interventions on Talquetamab-related Oral Toxicity
TALISMAN
View Trial
Verified
A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
MONUMENTAL-8
View Trial
Verified
Phase 1/2 Clinical Trial Evaluating the Safety, Effectiveness and Best Dose of Elranatamab Combined with Different Anti-Cancer Therapies in Participants with...
MAGNETISMM-4
View Trial
Verified
Phase 1B / 2 Study of Selinexor in Combination With Other Treatments for Relapsed/Refractory and Newly Diagnosed Multiple Myeloma.
STOMP
View Trial
Verified
Phase 1B Study Evaluating Elranatamab in Combination with Carfilzomib/Dexamethasone or in Combination with PF-07901801 (maplirpacept) in Relapsed/Refractory ...
MAGNETISMM-20
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...
SELINEXOR
View Trial
Verified
A Study to See if Anti-BCMA CAR T-Cell Therapy Can Be Made from People with Multiple Myeloma Who Have Had a Stem Cell Transplant
IDE-CEL POST HEMATOPOIETIC CELL TRANSPLANT
View Trial
Verified
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
IBERDOMIDE AS MAINTENANCE THERAPY
View Trial
Verified
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)
IMPACT
View Trial
Verified
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
NUTRIVENTION-4
View Trial
Verified
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
MONUMENTAL-1
View Trial
Verified
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma (ADVANCE)
ADVANCE
View Trial
Verified
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
DARATUMUMAB COMBINATION THERAPY
View Trial
Verified
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
IBERDOMIDE
View Trial
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
View Trial
Verified
Phase 2 Clinical Trial Studying the Safety and Efficacy of bb2121 in Participants with Relapsed and Refractory Multiple Myeloma or Clinical High-Risk Multipl...
KARMMA-2
View Trial
Verified
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
VENETOCLAX AND TOCILIZUMAB FOR T(11;14)
View Trial
Verified
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
Verified
TriPRIL CAR T Cells in Multiple Myeloma
TRIPRIL CAR T
View Trial
Verified
Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy
SELINEXOR FOR LENALIDOMIDE-REFRACTORY PATIENTS
View Trial
Verified
Personalized Autologous Transplant for Multiple Myeloma
PERSONALIZED AUTOLOGOUS TRANSPLANT
View Trial
Verified
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
KPG-818
View Trial
Verified
Rifaximin in Patients With Monoclonal Gammopathy
RIFAXIMIN
View Trial
Verified
Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma
CAR138 T-CELLS
View Trial
Verified
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
RUXOLITINIB
View Trial
Verified
A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma
DREAMM9
View Trial
Verified
A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function
DREAMM13
View Trial
Verified
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
DREAMM12
View Trial
Verified
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge)
SELVEDGE
View Trial
Verified
Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
BELANTAMAB MAFADOTIN MAINTENANCE THERAPY
View Trial
Verified
A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants With Relapsed an...
CA088-1005
View Trial
Verified
A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or R...
BMS-986453
View Trial
Verified
A Phase 1 Randomized, Open Label Pharmacokinetic Comparability Study Comparing Pre- and Post-change Teclistamab in Participants With Relapsed/Refractory Mult...
MAJESTEC-10
View Trial
Verified
PTSD Mobile App for Cancer Survivors
PTSD MOBILE APP
View Trial
Verified
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
View Trial
Verified
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
View Trial
Verified
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
STOPPING MAINTENANCE THERAPY
View Trial
Verified
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Mult...
NUTRIVENTION3
View Trial
Verified
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy (PEACE)
PEACE
View Trial
Verified
Platform Study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Mu...
DREAMM5
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
Expanded Access Request Program for Belantamab Mafodotin in Multiple Myeloma
EXPANDED ACCESS REQUEST FOR BELANTAMAB MAFODOTIN
View Trial
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autole...
CARTITUDE-6
View Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering ...
DETER-SMM
View Trial
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...
DRAMMATIC
View Trial
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE ...
EQUATE
View Trial
A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants Wi...
MAJESTEC-7
View Trial
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a ...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCE
View Trial
Elranatamab Post Trial Access: An Open-Label, Single-Arm Study For Participants with Multiple Myeloma Conti...
MAGNETISMM-15
View Trial
A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in C...
MONUMENTAL-6
View Trial
A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies...
CERVINO
View Trial
A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Ver...
IMMAGINE-3
View Trial
Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2...
FONDO-LOW
View Trial
A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of BMS-986393, a GP...
QUINTESSENTIAL-2
View Trial
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-c...
RADIATION AFTER BCMA CAR-T THERAPY
View Trial
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
ISATUXIMAB DURING STEM CELL TRANSPLANT
View Trial
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
MILESTONE
View Trial
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma
IMMAGINE-1
View Trial
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
IMPEDE
View Trial
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myelom...
VICD
View Trial
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma
ISATUXIMAB
View Trial
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation B...
EVOMELA® COMBINATION CONDITIONING THERAPY
View Trial
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
SELINEXOR
View Trial
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate...
CURCUMIN AND PIPERINE
View Trial
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
IMMUNO-PRISM
View Trial
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple...
BELANTAMAB MAFODOTIN
View Trial
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...
SELINEXOR
View Trial
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
View Trial
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
LEFLUNOMIDE
View Trial
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...
SUBQ DARATUMUMAB IN ELDERLY PATIENTS
View Trial
DARA RVD For High Risk SMM
PRISM
View Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
LOW-DOSE RADIOTHERAPY FOR BONE METASTASES
View Trial
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
ISA-CAPED
View Trial
Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multipl...
AMBUSH
View Trial
Isatuximab Plus Lenalidomide and Dexamethasone for Frail and/or Much Older Patients With Newly Diagnosed Mu...
ISATUXIMAB IN FRAIL PATIENTS
View Trial
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
BELANTAMAB MAFODOTIN COMBINATION THERAPY
View Trial
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
REACH
View Trial
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...
INVESTIGATIONAL CORD BLOOD UNITS
View Trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
CD38-TARGETED IMMUNOPET
View Trial
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...
D-CLAPD
View Trial
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
View Trial
CAR- PRISM (PRecision Intervention Smoldering Myeloma)
CAR-PRISM
View Trial
Phase II Study on Acalabrutinib and Anti-CD20 Antibody in Patients With Predominantly Demyelinating Neuropa...
ACALABRUTINIB
View Trial
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP
View Trial
Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
POST-TRANSPLANT MAINTENANCE THERAPY
View Trial
Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...
BELANTAMAB MAFODOTIN
View Trial
Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy for Relapsed/Refractory Multipl...
CEVOSTAMAB AFTER CAR-T CELL THERAPY
View Trial
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
BELANTAMAB MAFODOTIN IN THE COMMUNITY SETTING
View Trial
Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients...
IBER-KDD
View Trial
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
CAR T IN PATIENTS WITH RENAL IMPAIRMENT
View Trial
A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...
ISABELA
View Trial
Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
ISATUXIMAB COMBINATION THERAPY
View Trial
Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple...
TECLISTAMAB
View Trial
A Study of Outpatient Administration of Teclistamab, a BCMA-targeting Bispecific Antibody, in Multiple Myel...
TECLISTAMAB
View Trial
Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANT
View Trial
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPY
View Trial
Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) With Post-Tra...
POST-TRANSPLANT CYTOXAN
View Trial
Geriatric (G) Assessment Guided Optimization (O) to Accelerate Functional Recovery After Chimeric Antigen R...
GOCART
View Trial
Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma
TALQUETAMAB CONSOLIDATION AFTER BCMA CAR-T
View Trial
A Phase II Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab for Patients With...
CYBORD PLUS DARATUMUMAB
View Trial
Teclistamab or Talquetamab in Combination With Daratumumab SC for High-Risk Smoldering Myeloma: A Clinical ...
REVIVE
View Trial
A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma
18F-FLUCICLOVINE PET / CT SCAN
View Trial
IBEX: Phase 2 Trial of Iberdomide + SQ Daratumumab as Post-Autologous Stem Cell Transplant Maintenance Ther...
IBEX
View Trial
MRD-Guided Sequential Therapy For Deep Response in Newly Diagnosed Multiple Myeloma - MASTER-2 Trial
MASTER-2
View Trial
Phase II Trial for Evaluation of Alternate Doses and Dosing Schedules of Belantamab Mafodotin in Triple-Cla...
DIFFERENT DOSES OF BELANTAMAB MAFODOTIN
View Trial
A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With a...
GPC-100
View Trial
A Phase 2 Study of Elranatamab as Consolidation After Idecabtagene Vicleucel in Relapsed Refractory Multipl...
ELRANATAMAB AS CONSOLIDATION
View Trial
Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopat...
LINKER-MGUS1
View Trial
Phase IIa Study to Evaluate Daratumumab for Polyneuropathy Associated With MGUS
DARA-MGUS
View Trial
A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Di...
DARA-SVD VS. DARA-RVD
View Trial
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positiv...
HEME-18
View Trial
Phase II Trial of Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to Treatment With Teclistamab ...
SILTUXIMAB
View Trial
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMAB
View Trial
MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM
HORIZON ADAPTIVE PLATFORM
View Trial
Phase 2 Trial of Belantamab Mafodotin Consolidation Treatment in Patients With Multiple Myeloma and MRD Pos...
BELANTAMAB MAFODOTIN CONSOLIDATION
View Trial
Immuno-consolidation for Newly Diagnosed Multiple Myeloma Using Lack of MRD Negativity After Initial cOmbin...
IMMUNOPLANT
View Trial
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multip...
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T
View Trial
Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administrati...
CANCER CARE BEYOND WALLS
View Trial
A Phase 2 Randomized, Multi-center Study of GEO-CMO4S1 (SARS-CoV-2 Vaccine) Versus mRNA SARS-CoV-2 Vaccine ...
GEO-CM04S1 VS MRNA SARS-COV-2 VACCINE
View Trial
A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) a...
CRS AND ICANS TREATMENT
View Trial
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autolo...
BELANTAMAB MAFODOTIN OR LENALIDOMIDE MAINTENANCE
View Trial
A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Re...
AUTOLOGOUS T-CELLS
View Trial
Combination Post-transplant Consolidation Therapy With Isatuximab, Lenalidomide, Dexamethasone (IsaRD) in M...
EMAT
View Trial
An Attenuated Schedule Dara-RVd Induction for Patients With Newly Diagnosed Multiple Myeloma Who Are Eligib...
DARATUMUMAB COMBINATION INDUCTION
View Trial
A Study of Elranatamab Management With Outpatient and Intermittent Dosing in Relapsed/Refractory Multiple M...
EMBRACE
View Trial
An Open-Label, Non-Randomized, Multicenter, Phase II Study to Study the Efficacy of Talquetamab (JNJ-644075...
OPTIMMAL
View Trial
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic He...
ISATUXIMAB AFTER ALLOGENEIC STEM CELL TRANSPLANT
View Trial
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
MRD-GUIDED ELRANATAMAB MAINTENANCE THERAPY
View Trial
Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multip...
ULTRAFRAILMM
View Trial
Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Respon...
NIVOLUMAB POST TREATMENT WITH IDE-CEL
View Trial
A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Au...
AMMBITION
View Trial
Phase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesr...
MELPHALAN WITH OR WITHOUT SILTUXIMAB
View Trial
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multip...
RADIOIMMUNOTHERAPY
View Trial
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for the Treatment of Newly Diagnosed Multiple Myelom...
IDEAL
View Trial
Adoptive Transfer of MUC1 Activated T Cells for the Treatment of MUC1 Positive Recurrent or Refractory Mult...
MUC1 ACTIVATED T CELLS
View Trial
A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzom...
BGB-11417
View Trial
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
BELANTAMAB MAFODOTIN AND ELOTUZUMAB
View Trial
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...
APG-2575
View Trial
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
HDP-101
View Trial
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide (COMMANDER)
COMMANDER
View Trial
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
View Trial
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Mul...
CEMSIDOMIDE (CFT7455)
View Trial
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
TASQUINIMOD
View Trial
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
APG-2575
View Trial
High Dose Ascorbic Acid for Plasma Cell Disorders
HIGH-DOSE ASCORBIC ACID
View Trial
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Mult...
CS1-CAR T CELLS
View Trial
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...
MONUMENTAL-1
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma (CarMob)
CARMOB
View Trial
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
IBERDOMIDE COMBINATION THERAPY (KID)
View Trial
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-383 in C...
ABBV-383
View Trial
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)
P-BCMA-ALLO1
View Trial
LMY-920 for Treatment of Relapsed or Refractory Myeloma (LMY-920-002)
LMY-920
View Trial
A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Mul...
IBERDOMIDE COMBINATION THERAPY
View Trial
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
SELINEXOR
View Trial
Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma
ISB 1442
View Trial
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
NK CELL THERAPY WITH BHV-1100
View Trial
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
MMSET INHIBITOR
View Trial
A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy...
CAMMOUFLAGE
View Trial
A Phase Ib Clinical Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A...
BCMA CAR-T CELL INJECTION (CT103A)
View Trial
A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed...
ABBV-383
View Trial
Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patient...
LINKER-MM4
View Trial
VitD3 Supplementation in Patients With Multiple Myeloma
VITAMIN D
View Trial
Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...
ITACITINIB
View Trial
Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
IXAZOMIB COMBINATION THERAPY
View Trial
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antige...
AUTOLOGOUS STEM CELL TRANSPLANT POST CAR-T
View Trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
PET IMAGING
View Trial
A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection An...
REDIRECTT-1
View Trial
A Phase 1b/2 Study of GC012F, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell ...
GCO12F CAR-T
View Trial
A Phase Ib Study to Evaluate Safety and Persistence of ex Vivo Expanded Universal Donor NK Cells in Combina...
NK CELLS PLUS VACTOSERTIB
View Trial
Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
ELOTUZUMAB COMBINATION THERAPY
View Trial
Phase I Study of BCMA-TGF-BETA Insensitive Armored CAR T Cells in Patients With Relapsed and/or Refractory ...
BCMA-TGF-BETA INSENSITIVE ARMORED CAR T CELLS
View Trial
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Le...
LP-118
View Trial
Phase 1 Study of Lintivirally Transduced T Cells Engineered to Contain Anti-CD38 Linked to TCRζ and 4-1BB S...
CART 38
View Trial
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...
VENETOCLAX PLUS LENALIDOMIDE
View Trial
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...
LINVOSELTAMAB
View Trial
A Phase 1 Study of Mezigdomide (CC-92480) and Dexamethasone Post Idecabtagene Vicleucel in Relapsed Multipl...
MEZIGDOMIDE POST ABECMA TREATMENT
View Trial
Phase I/II Trial of Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
MEZIGDOMIDE PLUS IXAZOMIB
View Trial
A Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Administration o...
STAR-LLD
View Trial
Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patien...
BELUMOSUDIL MESYLATE
View Trial
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/​Refractory M...
AZD0305
View Trial
Phase 1/2 Study of IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Ad...
IDP-023
View Trial
A Phase 1 First-in-human Dose-escalation and Dose-expansion Study of BMF-219, an Oral Covalent Menin Inhibi...
BMF-219
View Trial
Remote Monitoring With Health-Coaching for Lifestyle Changes in Older Patients With Multiple Myeloma
REMOTE MONITORING OF OLDER PATIENTS
View Trial
Phase 1 Dose-Escalation and Dose-Expansion Study of the Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in S...
WS-CART-CS1
View Trial
A Phase Ib Study of TGFbi NK Cells and Isatuximab for Myeloma Relapsed/Refractory to BCMA Targeting Therapy
TGFBI NK CELLS
View Trial
A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Re...
MAGNETISMM-30
View Trial
Phase I/II Trial of Cord Blood-derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Recepto...
NY-ESO-1 TCR/IL-15 NK
View Trial
An i3+3 Phase I Hypofractionation Trial for Multiple Myeloma
RADIATION TO TREAT MULTIPLE MYELOMA
View Trial
Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
DC15-MM-01
View Trial
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
HIGH DOSE ASCORBIC ACID W/ MELPHALAN
View Trial
A Phase I/II Study to Assess the Safety and Tolerability of the Combination of Oral ON 123300 (Narazaciclib...
ON 123300 (NARAZACICLIB) AND DEXAMETHASONE
View Trial
A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Tre...
TALQUETAMAB WITH IBERDOMIDE
View Trial
A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and...
ORICAR-017 - RIGEL STUDY
View Trial
Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants Wit...
JNJ-79635322
View Trial
VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia,...
VSV-HIFNBETA-NIS
View Trial
Phase 1-2 UMBRELLA Trial Evaluating Isatuximab With or Without Dexamethasone in Combination With Novel Agen...
ISATUXIMAB IN COMBINATION WITH NOVEL AGENTS
View Trial
Multi-institutional Prospective Pilot Study of Radiology Evaluation of Acute Leukemia Infiltration analyZed...
REALIZE
View Trial
Phase Ib Trial of Low-Dose Selinexor (KPT-330) in Combination With Choline Salicylate (CS) for the Treatmen...
SELINEXOR WITH CHOLINE SALICYLATE
View Trial
A Phase 1b, Dose Escalation/Dose Expansion, Multicenter, Open-Label Study to Assess the Safety and Tolerabi...
OPN-662
View Trial
A Phase 1b, Multicenter, Open-Label, Study to Investigate the Safety and Efficacy of CLN-619 (Anti-MICA/MIC...
CLN-619
View Trial
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
ELOTUZUMAB + IBERDOMIDE POST ABECMA
View Trial
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...
SCOPE
View Trial
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell My...
ATRA
View Trial
A Pilot Study of the Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Recon...
CYT107
View Trial
A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Fol...
MOTIXAFORTIDE DOSING
View Trial
A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally...
QXL138AM
View Trial
A Phase 1, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agen...
ISB 2001
View Trial
A Pilot Safety and Feasibility Study of Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide ...
CAR-T FOR PATIENTS WITH RENAL IMPAIRMENT
View Trial
A Multicenter, Phase 1b, Open-label Study of ABBV-383 Administered Subcutaneously in Subjects With Relapsed...
ABBV-383
View Trial
A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedul...
RADIATION + TALQUETAMAB FOR EXTRAMEDULLARY DISEASE
View Trial
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B
64CU-LLP2A-PET/CT
View Trial
A Phase 1b Trial of Teclistamab in Combination With Iberdomide for Relapsed/Refractory Multiple Myeloma
TECVAYLI
View Trial
Phase 1 Trial of SX-682, a CXCR 1/2 Inhibitor, in Combination With Standard of Care Treatment in Patients W...
SX-682
View Trial
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precurso...
TRANSFORMM
View Trial
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With ...
HIGH THROUGHPUT DRUG SENSITIVITY AND GENOMICS
View Trial
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
CHEMOSENSITIVITY STUDY
View Trial
Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
ORIGIN STUDY
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
TISSUE BANKING
View Trial
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...
MEDULLA
View Trial
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab
DIGITAL HEALTH COACHING
View Trial
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MR...
HEME-20
View Trial
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
POST AUTOLOGOUS STEM CELL TRANSPLANT MAINTENANCE
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
NON-CHEMOTHERAPEUTIC INTERVENTIONS
View Trial
PROFAST Intervention in Precursor Multiple Myeloma
PROFAST
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS
View Trial
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
PROTECT
View Trial
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Sym...
AMBIENT LIGHT
View Trial
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...
ASH RESEARCH COLLABORATIVE DATA HUB
View Trial
Exploratory Study of Fluoroquinolone Resistance for Patients Undergoing Autologous Hematopoietic Stem Cell ...
FLUOROQUINOLONE RESISTANCE
View Trial
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The ...
MULTIPLE MYELOMA BIOREPOSITORY
View Trial
The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...
REIKI
View Trial
The Role of the Comprehensive Geriatric Assessment in Elderly Patients With Multiple Myeloma: A Single Cent...
COMPREHENSIVE GERIATRIC ASSESSMENT
View Trial
Evaluating Patient-Reported Outcomes and Wearable Data Among Individuals With Relapsed/Refractory Multiple ...
DIGITAL HEALTH COACHING
View Trial
Cardiovascular Reserve Evaluation in Survivors of Transplantation (CREST)
CREST STUDY
View Trial
The Prospective Collection, Storage and Reporting of Data on Patients
PATIENT REGISTRY: UNDERGOING STEM CELL TRANSPLANT
View Trial
An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients Wit...
APP SICP
View Trial
Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progre...
PCROWD
View Trial
Cancer Experience Registry: An Online Research Study to Understand the Experiences of Cancer Patients and C...
CER
View Trial
Carolina Senior: UNC Registry for Older Cancer Patients
REGISTRY OF OLDER PATIENTS WITH CANCER
View Trial
Tissue Procurement For Hematolymphoid Conditions
TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION
View Trial
Microbial Changes in Response to a Plant Based Diet and/or Supplements in SMM Patients: A National Multi-Ar...
SUPPLEMENTS OR PLANT-BASED DIET FOR SMM PATIENTS
View Trial
A Randomized Pilot Study of Yoga Intervention in Patients With Multiple Myeloma on Active Therapy
WEEKLY YOGA
View Trial
Randomized Controlled Trial of a Psychosocial Mobile Application (THRIVE-M) for Patients Living With Multip...
THRIVE-M
View Trial
Sleep Apnea in Patients With MGUS and Multiple Myeloma
SLEEP APNEA
View Trial
Testing Two Implementation Strategies in Collecting ePRO Among Multiple Myeloma Patients
EPRO4MM
View Trial
Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Diso...
IDENTIFYING BARRIERS TO CELLULAR THERAPY
View Trial
Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For ...
EXERCISE PREHABILITATION
View Trial
cfDNA Assay Multicenter Prospective Observational Validation for Early Cancer Detection, Minimal Residual D...
CAMPERR
View Trial
Pilot Study of Daratumumab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone (Dara-CyBorD...
DARATUMUMAB FOR PATIENTS WITH RENAL FAILURE
View Trial
Blinded Reference Set for Multicancer Early Detection Blood Tests
EARLY DETECTION BLOOD TESTS
View Trial
A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma
PRAGMMATIC
View Trial
The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A ...
IMPACT OF NON-PROFIT ON PATIENT OUTCOMES & CARE
View Trial
Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Tra...
PROACTIVE
View Trial
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
SPOTLIGHT
View Trial
Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transpl...
CHAPLAIN-DELIVERED MEDITATION
View Trial
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
WU-PE-CGS
View Trial
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
AMYLOIDOSIS SCREENING
View Trial
Pilot Trial of Homebound Stem Cell Transplantation
HOMEBOUND STEM CELL TRANSPLANT
View Trial
Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Trans...
MUSCLE STIMULATION DURING STEM CELL TRANSPLANT
View Trial
Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cel...
PREHABILITATION FEASIBILITY
View Trial
Integrated Actionable Aging Assessment for Cancer Patients Pilot
AGING ASSESSMENT
View Trial
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
DISCOVERY
View Trial
Cancer Moonshot Biobank Research Protocol
CANCER MOONSHOT BIOBANK
View Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
GENETIC STUDIES
View Trial
Cancer Sequencing Guided Personalized and Precision Medicine Platform in Multiple Myeloma
PRECISION MEDICINE STUDY
View Trial
Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma
BIOMARKER FOR INFECTION RISK
View Trial
Non-Invasive Minimal Residual Disease (MRD) Assessment in Multiple Myeloma Via Functional Imaging and Liqui...
NIRVANA
View Trial
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
CARE-HEME
View Trial
A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Dive...
PREBIOTICS AFTER AUTOLOGOUS STEM CELL TRANSPLANT
View Trial
Prospective, Digitized Dietary Intake Monitoring in Individuals Undergoing Cancer Therapy
DIETARY INTAKE MONITORING
View Trial
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS
View Trial
An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
MOLECULAR PROFILING
View Trial
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogen...
TREATMENT EXPERIENCE OF PATIENTS
View Trial
Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
HEME HOSPICE - HOME TRANSFUSION PROGRAM
View Trial
Provide Compassionate Use' of REGN5458 for Patients with Relapsed or Refractory Multiple Myeloma
LINVOSELTAMAB - COMPASSIONATE USE
View Trial
Implementing a Plant-Based Whole-Foods Meal Delivery Service for Patients Undergoing Autologous Hematopoiet...
PLANT-BASED WHOLE-FOODS MEAL DELIVERY
View Trial
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
WEARABLE SENSOR POST CAR-T CELL THERAPY
View Trial
Understanding the Mechanisms of Clonal and Non-Clonal Cytopenia Following CAR-T Therapy
UNEXPLAINED CYTOPENIA POST-CAR-T CELL THERAPY
View Trial
Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Verified
Phase 3 Clinical Trial Comparing Iberdomide VS Lenalidomide as Maintenance Therapy Following Autologous Stem Cell Transplant in Participants with Newly Diagn...
EXCALIBER-MAINTENANCE
View Trial
Verified
A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
MONUMENTAL-8
View Trial
Verified
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)
IMPACT
View Trial
Verified
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma (ADVANCE)
ADVANCE
View Trial
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
View Trial
Verified
A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma
DREAMM9
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autole...
CARTITUDE-6
View Trial
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...
DRAMMATIC
View Trial
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE ...
EQUATE
View Trial
A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants Wi...
MAJESTEC-7
View Trial
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a ...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCE
View Trial
Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2...
FONDO-LOW
View Trial
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
MILESTONE
View Trial
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myelom...
VICD
View Trial
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma
ISATUXIMAB
View Trial
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
SELINEXOR
View Trial
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...
SUBQ DARATUMUMAB IN ELDERLY PATIENTS
View Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
LOW-DOSE RADIOTHERAPY FOR BONE METASTASES
View Trial
Isatuximab Plus Lenalidomide and Dexamethasone for Frail and/or Much Older Patients With Newly Diagnosed Mu...
ISATUXIMAB IN FRAIL PATIENTS
View Trial
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
REACH
View Trial
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...
INVESTIGATIONAL CORD BLOOD UNITS
View Trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
CD38-TARGETED IMMUNOPET
View Trial
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
CAR T IN PATIENTS WITH RENAL IMPAIRMENT
View Trial
A Phase II Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab for Patients With...
CYBORD PLUS DARATUMUMAB
View Trial
A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma
18F-FLUCICLOVINE PET / CT SCAN
View Trial
MRD-Guided Sequential Therapy For Deep Response in Newly Diagnosed Multiple Myeloma - MASTER-2 Trial
MASTER-2
View Trial
A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Di...
DARA-SVD VS. DARA-RVD
View Trial
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMAB
View Trial
Phase 2 Trial of Belantamab Mafodotin Consolidation Treatment in Patients With Multiple Myeloma and MRD Pos...
BELANTAMAB MAFODOTIN CONSOLIDATION
View Trial
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autolo...
BELANTAMAB MAFODOTIN OR LENALIDOMIDE MAINTENANCE
View Trial
An Attenuated Schedule Dara-RVd Induction for Patients With Newly Diagnosed Multiple Myeloma Who Are Eligib...
DARATUMUMAB COMBINATION INDUCTION
View Trial
An Open-Label, Non-Randomized, Multicenter, Phase II Study to Study the Efficacy of Talquetamab (JNJ-644075...
OPTIMMAL
View Trial
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
MRD-GUIDED ELRANATAMAB MAINTENANCE THERAPY
View Trial
Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multip...
ULTRAFRAILMM
View Trial
A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Au...
AMMBITION
View Trial
Phase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesr...
MELPHALAN WITH OR WITHOUT SILTUXIMAB
View Trial
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for the Treatment of Newly Diagnosed Multiple Myelom...
IDEAL
View Trial
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
View Trial
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma (CarMob)
CARMOB
View Trial
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
NK CELL THERAPY WITH BHV-1100
View Trial
Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patient...
LINKER-MM4
View Trial
VitD3 Supplementation in Patients With Multiple Myeloma
VITAMIN D
View Trial
Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...
ITACITINIB
View Trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
PET IMAGING
View Trial
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...
VENETOCLAX PLUS LENALIDOMIDE
View Trial
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B
64CU-LLP2A-PET/CT
View Trial
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
CHEMOSENSITIVITY STUDY
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
TISSUE BANKING
View Trial
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...
MEDULLA
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
NON-CHEMOTHERAPEUTIC INTERVENTIONS
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS
View Trial
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Sym...
AMBIENT LIGHT
View Trial
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...
ASH RESEARCH COLLABORATIVE DATA HUB
View Trial
The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...
REIKI
View Trial
The Role of the Comprehensive Geriatric Assessment in Elderly Patients With Multiple Myeloma: A Single Cent...
COMPREHENSIVE GERIATRIC ASSESSMENT
View Trial
An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients Wit...
APP SICP
View Trial
Tissue Procurement For Hematolymphoid Conditions
TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION
View Trial
Sleep Apnea in Patients With MGUS and Multiple Myeloma
SLEEP APNEA
View Trial
Testing Two Implementation Strategies in Collecting ePRO Among Multiple Myeloma Patients
EPRO4MM
View Trial
Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For ...
EXERCISE PREHABILITATION
View Trial
cfDNA Assay Multicenter Prospective Observational Validation for Early Cancer Detection, Minimal Residual D...
CAMPERR
View Trial
Blinded Reference Set for Multicancer Early Detection Blood Tests
EARLY DETECTION BLOOD TESTS
View Trial
A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma
PRAGMMATIC
View Trial
Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Tra...
PROACTIVE
View Trial
Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transpl...
CHAPLAIN-DELIVERED MEDITATION
View Trial
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
WU-PE-CGS
View Trial
Pilot Trial of Homebound Stem Cell Transplantation
HOMEBOUND STEM CELL TRANSPLANT
View Trial
Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Trans...
MUSCLE STIMULATION DURING STEM CELL TRANSPLANT
View Trial
Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cel...
PREHABILITATION FEASIBILITY
View Trial
Integrated Actionable Aging Assessment for Cancer Patients Pilot
AGING ASSESSMENT
View Trial
Cancer Moonshot Biobank Research Protocol
CANCER MOONSHOT BIOBANK
View Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
GENETIC STUDIES
View Trial
Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma
BIOMARKER FOR INFECTION RISK
View Trial
Non-Invasive Minimal Residual Disease (MRD) Assessment in Multiple Myeloma Via Functional Imaging and Liqui...
NIRVANA
View Trial
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
CARE-HEME
View Trial
A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Dive...
PREBIOTICS AFTER AUTOLOGOUS STEM CELL TRANSPLANT
View Trial
Prospective, Digitized Dietary Intake Monitoring in Individuals Undergoing Cancer Therapy
DIETARY INTAKE MONITORING
View Trial
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS
View Trial
An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
MOLECULAR PROFILING
View Trial
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogen...
TREATMENT EXPERIENCE OF PATIENTS
View Trial
Implementing a Plant-Based Whole-Foods Meal Delivery Service for Patients Undergoing Autologous Hematopoiet...
PLANT-BASED WHOLE-FOODS MEAL DELIVERY
View Trial
Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in P...
EXCALIBER RRMM
View Trial
Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Re...
SUCCESSOR-2
View Trial
Verified
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...
MONUMENTAL-3
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...
MAGNETISMM-32
View Trial
Verified
A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...
LINKER-MM3
View Trial
Verified
Phase 2, Open-Label Study Evaluating the Use of an Investigational CAR-T Cell therapy in Participants with Multiple Myeloma
CARTITUDE-2
View Trial
Verified
Phase 1B / 2 Study of Selinexor in Combination With Other Treatments for Relapsed/Refractory and Newly Diagnosed Multiple Myeloma.
STOMP
View Trial
Verified
Phase 1B Study Evaluating Elranatamab in Combination with Carfilzomib/Dexamethasone or in Combination with PF-07901801 (maplirpacept) in Relapsed/Refractory ...
MAGNETISMM-20
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...
SELINEXOR
View Trial
Verified
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)
IMPACT
View Trial
Verified
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
DARATUMUMAB COMBINATION THERAPY
View Trial
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
View Trial
Verified
Phase 2 Clinical Trial Studying the Safety and Efficacy of bb2121 in Participants with Relapsed and Refractory Multiple Myeloma or Clinical High-Risk Multipl...
KARMMA-2
View Trial
Verified
Personalized Autologous Transplant for Multiple Myeloma
PERSONALIZED AUTOLOGOUS TRANSPLANT
View Trial
Verified
A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function
DREAMM13
View Trial
Verified
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
DREAMM12
View Trial
Verified
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge)
SELVEDGE
View Trial
Verified
Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
BELANTAMAB MAFADOTIN MAINTENANCE THERAPY
View Trial
Verified
A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants With Relapsed an...
CA088-1005
View Trial
Verified
A Phase 1 Randomized, Open Label Pharmacokinetic Comparability Study Comparing Pre- and Post-change Teclistamab in Participants With Relapsed/Refractory Mult...
MAJESTEC-10
View Trial
Verified
PTSD Mobile App for Cancer Survivors
PTSD MOBILE APP
View Trial
Verified
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
STOPPING MAINTENANCE THERAPY
View Trial
Verified
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy (PEACE)
PEACE
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...
DRAMMATIC
View Trial
A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in C...
MONUMENTAL-6
View Trial
A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies...
CERVINO
View Trial
A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Ver...
IMMAGINE-3
View Trial
Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2...
FONDO-LOW
View Trial
A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of BMS-986393, a GP...
QUINTESSENTIAL-2
View Trial
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-c...
RADIATION AFTER BCMA CAR-T THERAPY
View Trial
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
ISATUXIMAB DURING STEM CELL TRANSPLANT
View Trial
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma
IMMAGINE-1
View Trial
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
IMPEDE
View Trial
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple...
BELANTAMAB MAFODOTIN
View Trial
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...
SELINEXOR
View Trial
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
LEFLUNOMIDE
View Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
LOW-DOSE RADIOTHERAPY FOR BONE METASTASES
View Trial
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
ISA-CAPED
View Trial
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...
INVESTIGATIONAL CORD BLOOD UNITS
View Trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
CD38-TARGETED IMMUNOPET
View Trial
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...
D-CLAPD
View Trial
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP
View Trial
Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...
BELANTAMAB MAFODOTIN
View Trial
Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients...
IBER-KDD
View Trial
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
CAR T IN PATIENTS WITH RENAL IMPAIRMENT
View Trial
A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...
ISABELA
View Trial
Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
ISATUXIMAB COMBINATION THERAPY
View Trial
Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple...
TECLISTAMAB
View Trial
Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANT
View Trial
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPY
View Trial
Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma
TALQUETAMAB CONSOLIDATION AFTER BCMA CAR-T
View Trial
A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma
18F-FLUCICLOVINE PET / CT SCAN
View Trial
IBEX: Phase 2 Trial of Iberdomide + SQ Daratumumab as Post-Autologous Stem Cell Transplant Maintenance Ther...
IBEX
View Trial
Phase 2 Trial of Belantamab Mafodotin Consolidation Treatment in Patients With Multiple Myeloma and MRD Pos...
BELANTAMAB MAFODOTIN CONSOLIDATION
View Trial
A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) a...
CRS AND ICANS TREATMENT
View Trial
A Study of Elranatamab Management With Outpatient and Intermittent Dosing in Relapsed/Refractory Multiple M...
EMBRACE
View Trial
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic He...
ISATUXIMAB AFTER ALLOGENEIC STEM CELL TRANSPLANT
View Trial
Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Respon...
NIVOLUMAB POST TREATMENT WITH IDE-CEL
View Trial
Phase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesr...
MELPHALAN WITH OR WITHOUT SILTUXIMAB
View Trial
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multip...
RADIOIMMUNOTHERAPY
View Trial
A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzom...
BGB-11417
View Trial
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...
APG-2575
View Trial
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
HDP-101
View Trial
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
View Trial
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
TASQUINIMOD
View Trial
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
APG-2575
View Trial
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...
MONUMENTAL-1
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma (CarMob)
CARMOB
View Trial
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)
P-BCMA-ALLO1
View Trial
A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Mul...
IBERDOMIDE COMBINATION THERAPY
View Trial
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
SELINEXOR
View Trial
A Phase Ib Clinical Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A...
BCMA CAR-T CELL INJECTION (CT103A)
View Trial
VitD3 Supplementation in Patients With Multiple Myeloma
VITAMIN D
View Trial
Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...
ITACITINIB
View Trial
Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
IXAZOMIB COMBINATION THERAPY
View Trial
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antige...
AUTOLOGOUS STEM CELL TRANSPLANT POST CAR-T
View Trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
PET IMAGING
View Trial
A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection An...
REDIRECTT-1
View Trial
Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
ELOTUZUMAB COMBINATION THERAPY
View Trial
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Le...
LP-118
View Trial
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...
VENETOCLAX PLUS LENALIDOMIDE
View Trial
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...
LINVOSELTAMAB
View Trial
Phase I/II Trial of Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
MEZIGDOMIDE PLUS IXAZOMIB
View Trial
A Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Administration o...
STAR-LLD
View Trial
Remote Monitoring With Health-Coaching for Lifestyle Changes in Older Patients With Multiple Myeloma
REMOTE MONITORING OF OLDER PATIENTS
View Trial
A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Re...
MAGNETISMM-30
View Trial
A Phase I/II Study to Assess the Safety and Tolerability of the Combination of Oral ON 123300 (Narazaciclib...
ON 123300 (NARAZACICLIB) AND DEXAMETHASONE
View Trial
A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Tre...
TALQUETAMAB WITH IBERDOMIDE
View Trial
A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and...
ORICAR-017 - RIGEL STUDY
View Trial
Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants Wit...
JNJ-79635322
View Trial
Phase 1-2 UMBRELLA Trial Evaluating Isatuximab With or Without Dexamethasone in Combination With Novel Agen...
ISATUXIMAB IN COMBINATION WITH NOVEL AGENTS
View Trial
Multi-institutional Prospective Pilot Study of Radiology Evaluation of Acute Leukemia Infiltration analyZed...
REALIZE
View Trial
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...
SCOPE
View Trial
A Pilot Study of the Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Recon...
CYT107
View Trial
A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedul...
RADIATION + TALQUETAMAB FOR EXTRAMEDULLARY DISEASE
View Trial
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B
64CU-LLP2A-PET/CT
View Trial
Phase 1 Trial of SX-682, a CXCR 1/2 Inhibitor, in Combination With Standard of Care Treatment in Patients W...
SX-682
View Trial
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
CHEMOSENSITIVITY STUDY
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
TISSUE BANKING
View Trial
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...
MEDULLA
View Trial
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab
DIGITAL HEALTH COACHING
View Trial
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MR...
HEME-20
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
NON-CHEMOTHERAPEUTIC INTERVENTIONS
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS
View Trial
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Sym...
AMBIENT LIGHT
View Trial
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...
ASH RESEARCH COLLABORATIVE DATA HUB
View Trial
The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...
REIKI
View Trial
The Prospective Collection, Storage and Reporting of Data on Patients
PATIENT REGISTRY: UNDERGOING STEM CELL TRANSPLANT
View Trial
An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients Wit...
APP SICP
View Trial
Tissue Procurement For Hematolymphoid Conditions
TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION
View Trial
A Randomized Pilot Study of Yoga Intervention in Patients With Multiple Myeloma on Active Therapy
WEEKLY YOGA
View Trial
Randomized Controlled Trial of a Psychosocial Mobile Application (THRIVE-M) for Patients Living With Multip...
THRIVE-M
View Trial
Sleep Apnea in Patients With MGUS and Multiple Myeloma
SLEEP APNEA
View Trial
Testing Two Implementation Strategies in Collecting ePRO Among Multiple Myeloma Patients
EPRO4MM
View Trial
Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Diso...
IDENTIFYING BARRIERS TO CELLULAR THERAPY
View Trial
Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For ...
EXERCISE PREHABILITATION
View Trial
The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A ...
IMPACT OF NON-PROFIT ON PATIENT OUTCOMES & CARE
View Trial
Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Tra...
PROACTIVE
View Trial
Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transpl...
CHAPLAIN-DELIVERED MEDITATION
View Trial
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
WU-PE-CGS
View Trial
Pilot Trial of Homebound Stem Cell Transplantation
HOMEBOUND STEM CELL TRANSPLANT
View Trial
Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Trans...
MUSCLE STIMULATION DURING STEM CELL TRANSPLANT
View Trial
Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cel...
PREHABILITATION FEASIBILITY
View Trial
Cancer Moonshot Biobank Research Protocol
CANCER MOONSHOT BIOBANK
View Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
GENETIC STUDIES
View Trial
Cancer Sequencing Guided Personalized and Precision Medicine Platform in Multiple Myeloma
PRECISION MEDICINE STUDY
View Trial
Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma
BIOMARKER FOR INFECTION RISK
View Trial
Non-Invasive Minimal Residual Disease (MRD) Assessment in Multiple Myeloma Via Functional Imaging and Liqui...
NIRVANA
View Trial
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
CARE-HEME
View Trial
A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Dive...
PREBIOTICS AFTER AUTOLOGOUS STEM CELL TRANSPLANT
View Trial
Prospective, Digitized Dietary Intake Monitoring in Individuals Undergoing Cancer Therapy
DIETARY INTAKE MONITORING
View Trial
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS
View Trial
An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
MOLECULAR PROFILING
View Trial
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogen...
TREATMENT EXPERIENCE OF PATIENTS
View Trial
Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
HEME HOSPICE - HOME TRANSFUSION PROGRAM
View Trial
Implementing a Plant-Based Whole-Foods Meal Delivery Service for Patients Undergoing Autologous Hematopoiet...
PLANT-BASED WHOLE-FOODS MEAL DELIVERY
View Trial
Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Re...
SUCCESSOR-2
View Trial
Verified
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...
MONUMENTAL-3
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...
MAGNETISMM-32
View Trial
Verified
A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...
LINKER-MM3
View Trial
Verified
Phase 2, Open-Label Study Evaluating the Use of an Investigational CAR-T Cell therapy in Participants with Multiple Myeloma
CARTITUDE-2
View Trial
Verified
Phase 2 Study of BMS-986393, a GPRC5D-directed CART-Cell Therapy, in Participants with Relapsed or Refractory Multiple Myeloma
QUINTESSENTIAL
View Trial
Verified
A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
MONUMENTAL-8
View Trial
Verified
Phase 1/2 Clinical Trial Evaluating the Safety, Effectiveness and Best Dose of Elranatamab Combined with Different Anti-Cancer Therapies in Participants with...
MAGNETISMM-4
View Trial
Verified
Phase 1B / 2 Study of Selinexor in Combination With Other Treatments for Relapsed/Refractory and Newly Diagnosed Multiple Myeloma.
STOMP
View Trial
Verified
Phase 1B Study Evaluating Elranatamab in Combination with Carfilzomib/Dexamethasone or in Combination with PF-07901801 (maplirpacept) in Relapsed/Refractory ...
MAGNETISMM-20
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...
SELINEXOR
View Trial
Verified
A Study to See if Anti-BCMA CAR T-Cell Therapy Can Be Made from People with Multiple Myeloma Who Have Had a Stem Cell Transplant
IDE-CEL POST HEMATOPOIETIC CELL TRANSPLANT
View Trial
Verified
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)
IMPACT
View Trial
Verified
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
MONUMENTAL-1
View Trial
Verified
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
DARATUMUMAB COMBINATION THERAPY
View Trial
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
View Trial
Verified
Phase 2 Clinical Trial Studying the Safety and Efficacy of bb2121 in Participants with Relapsed and Refractory Multiple Myeloma or Clinical High-Risk Multipl...
KARMMA-2
View Trial
Verified
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
VENETOCLAX AND TOCILIZUMAB FOR T(11;14)
View Trial
Verified
TriPRIL CAR T Cells in Multiple Myeloma
TRIPRIL CAR T
View Trial
Verified
Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy
SELINEXOR FOR LENALIDOMIDE-REFRACTORY PATIENTS
View Trial
Verified
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
KPG-818
View Trial
Verified
Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma
CAR138 T-CELLS
View Trial
Verified
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
RUXOLITINIB
View Trial
Verified
A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function
DREAMM13
View Trial
Verified
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
DREAMM12
View Trial
Verified
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge)
SELVEDGE
View Trial
Verified
Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
BELANTAMAB MAFADOTIN MAINTENANCE THERAPY
View Trial
Verified
A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants With Relapsed an...
CA088-1005
View Trial
Verified
A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or R...
BMS-986453
View Trial
Verified
A Phase 1 Randomized, Open Label Pharmacokinetic Comparability Study Comparing Pre- and Post-change Teclistamab in Participants With Relapsed/Refractory Mult...
MAJESTEC-10
View Trial
Verified
PTSD Mobile App for Cancer Survivors
PTSD MOBILE APP
View Trial
Verified
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
STOPPING MAINTENANCE THERAPY
View Trial
Verified
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy (PEACE)
PEACE
View Trial
Verified
Platform Study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Mu...
DREAMM5
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
Expanded Access Request Program for Belantamab Mafodotin in Multiple Myeloma
EXPANDED ACCESS REQUEST FOR BELANTAMAB MAFODOTIN
View Trial
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...
DRAMMATIC
View Trial
A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in C...
MONUMENTAL-6
View Trial
A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies...
CERVINO
View Trial
A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Ver...
IMMAGINE-3
View Trial
Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2...
FONDO-LOW
View Trial
A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of BMS-986393, a GP...
QUINTESSENTIAL-2
View Trial
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-c...
RADIATION AFTER BCMA CAR-T THERAPY
View Trial
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma
IMMAGINE-1
View Trial
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
IMPEDE
View Trial
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...
SELINEXOR
View Trial
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
LEFLUNOMIDE
View Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
LOW-DOSE RADIOTHERAPY FOR BONE METASTASES
View Trial
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
ISA-CAPED
View Trial
Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multipl...
AMBUSH
View Trial
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...
INVESTIGATIONAL CORD BLOOD UNITS
View Trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
CD38-TARGETED IMMUNOPET
View Trial
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...
D-CLAPD
View Trial
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP
View Trial
Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...
BELANTAMAB MAFODOTIN
View Trial
Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy for Relapsed/Refractory Multipl...
CEVOSTAMAB AFTER CAR-T CELL THERAPY
View Trial
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
BELANTAMAB MAFODOTIN IN THE COMMUNITY SETTING
View Trial
Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients...
IBER-KDD
View Trial
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
CAR T IN PATIENTS WITH RENAL IMPAIRMENT
View Trial
A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...
ISABELA
View Trial
Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
ISATUXIMAB COMBINATION THERAPY
View Trial
Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple...
TECLISTAMAB
View Trial
Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANT
View Trial
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPY
View Trial
Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma
TALQUETAMAB CONSOLIDATION AFTER BCMA CAR-T
View Trial
A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma
18F-FLUCICLOVINE PET / CT SCAN
View Trial
IBEX: Phase 2 Trial of Iberdomide + SQ Daratumumab as Post-Autologous Stem Cell Transplant Maintenance Ther...
IBEX
View Trial
Phase II Trial for Evaluation of Alternate Doses and Dosing Schedules of Belantamab Mafodotin in Triple-Cla...
DIFFERENT DOSES OF BELANTAMAB MAFODOTIN
View Trial
A Phase 2 Study of Elranatamab as Consolidation After Idecabtagene Vicleucel in Relapsed Refractory Multipl...
ELRANATAMAB AS CONSOLIDATION
View Trial
Phase II Trial of Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to Treatment With Teclistamab ...
SILTUXIMAB
View Trial
Phase 2 Trial of Belantamab Mafodotin Consolidation Treatment in Patients With Multiple Myeloma and MRD Pos...
BELANTAMAB MAFODOTIN CONSOLIDATION
View Trial
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multip...
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T
View Trial
A Phase 2 Randomized, Multi-center Study of GEO-CMO4S1 (SARS-CoV-2 Vaccine) Versus mRNA SARS-CoV-2 Vaccine ...
GEO-CM04S1 VS MRNA SARS-COV-2 VACCINE
View Trial
A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) a...
CRS AND ICANS TREATMENT
View Trial
A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Re...
AUTOLOGOUS T-CELLS
View Trial
A Study of Elranatamab Management With Outpatient and Intermittent Dosing in Relapsed/Refractory Multiple M...
EMBRACE
View Trial
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic He...
ISATUXIMAB AFTER ALLOGENEIC STEM CELL TRANSPLANT
View Trial
Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Respon...
NIVOLUMAB POST TREATMENT WITH IDE-CEL
View Trial
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multip...
RADIOIMMUNOTHERAPY
View Trial
Adoptive Transfer of MUC1 Activated T Cells for the Treatment of MUC1 Positive Recurrent or Refractory Mult...
MUC1 ACTIVATED T CELLS
View Trial
A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzom...
BGB-11417
View Trial
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
BELANTAMAB MAFODOTIN AND ELOTUZUMAB
View Trial
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...
APG-2575
View Trial
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
HDP-101
View Trial
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
View Trial
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Mul...
CEMSIDOMIDE (CFT7455)
View Trial
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
TASQUINIMOD
View Trial
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
APG-2575
View Trial
High Dose Ascorbic Acid for Plasma Cell Disorders
HIGH-DOSE ASCORBIC ACID
View Trial
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Mult...
CS1-CAR T CELLS
View Trial
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...
MONUMENTAL-1
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)
P-BCMA-ALLO1
View Trial
LMY-920 for Treatment of Relapsed or Refractory Myeloma (LMY-920-002)
LMY-920
View Trial
A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Mul...
IBERDOMIDE COMBINATION THERAPY
View Trial
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
SELINEXOR
View Trial
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
MMSET INHIBITOR
View Trial
A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy...
CAMMOUFLAGE
View Trial
A Phase Ib Clinical Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A...
BCMA CAR-T CELL INJECTION (CT103A)
View Trial
A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed...
ABBV-383
View Trial
VitD3 Supplementation in Patients With Multiple Myeloma
VITAMIN D
View Trial
Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...
ITACITINIB
View Trial
Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
IXAZOMIB COMBINATION THERAPY
View Trial
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antige...
AUTOLOGOUS STEM CELL TRANSPLANT POST CAR-T
View Trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
PET IMAGING
View Trial
A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection An...
REDIRECTT-1
View Trial
A Phase 1b/2 Study of GC012F, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell ...
GCO12F CAR-T
View Trial
Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
ELOTUZUMAB COMBINATION THERAPY
View Trial
Phase I Study of BCMA-TGF-BETA Insensitive Armored CAR T Cells in Patients With Relapsed and/or Refractory ...
BCMA-TGF-BETA INSENSITIVE ARMORED CAR T CELLS
View Trial
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Le...
LP-118
View Trial
Phase 1 Study of Lintivirally Transduced T Cells Engineered to Contain Anti-CD38 Linked to TCRζ and 4-1BB S...
CART 38
View Trial
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...
VENETOCLAX PLUS LENALIDOMIDE
View Trial
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...
LINVOSELTAMAB
View Trial
A Phase 1 Study of Mezigdomide (CC-92480) and Dexamethasone Post Idecabtagene Vicleucel in Relapsed Multipl...
MEZIGDOMIDE POST ABECMA TREATMENT
View Trial
Phase I/II Trial of Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
MEZIGDOMIDE PLUS IXAZOMIB
View Trial
A Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Administration o...
STAR-LLD
View Trial
Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patien...
BELUMOSUDIL MESYLATE
View Trial
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/​Refractory M...
AZD0305
View Trial
Phase 1/2 Study of IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Ad...
IDP-023
View Trial
A Phase 1 First-in-human Dose-escalation and Dose-expansion Study of BMF-219, an Oral Covalent Menin Inhibi...
BMF-219
View Trial
Remote Monitoring With Health-Coaching for Lifestyle Changes in Older Patients With Multiple Myeloma
REMOTE MONITORING OF OLDER PATIENTS
View Trial
Phase 1 Dose-Escalation and Dose-Expansion Study of the Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in S...
WS-CART-CS1
View Trial
A Phase Ib Study of TGFbi NK Cells and Isatuximab for Myeloma Relapsed/Refractory to BCMA Targeting Therapy
TGFBI NK CELLS
View Trial
A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Re...
MAGNETISMM-30
View Trial
Phase I/II Trial of Cord Blood-derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Recepto...
NY-ESO-1 TCR/IL-15 NK
View Trial
Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
DC15-MM-01
View Trial
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
HIGH DOSE ASCORBIC ACID W/ MELPHALAN
View Trial
A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Tre...
TALQUETAMAB WITH IBERDOMIDE
View Trial
A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and...
ORICAR-017 - RIGEL STUDY
View Trial
Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants Wit...
JNJ-79635322
View Trial
Phase 1-2 UMBRELLA Trial Evaluating Isatuximab With or Without Dexamethasone in Combination With Novel Agen...
ISATUXIMAB IN COMBINATION WITH NOVEL AGENTS
View Trial
Multi-institutional Prospective Pilot Study of Radiology Evaluation of Acute Leukemia Infiltration analyZed...
REALIZE
View Trial
Phase Ib Trial of Low-Dose Selinexor (KPT-330) in Combination With Choline Salicylate (CS) for the Treatmen...
SELINEXOR WITH CHOLINE SALICYLATE
View Trial
A Phase 1b, Dose Escalation/Dose Expansion, Multicenter, Open-Label Study to Assess the Safety and Tolerabi...
OPN-662
View Trial
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
ELOTUZUMAB + IBERDOMIDE POST ABECMA
View Trial
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...
SCOPE
View Trial
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell My...
ATRA
View Trial
A Pilot Study of the Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Recon...
CYT107
View Trial
A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally...
QXL138AM
View Trial
A Multicenter, Phase 1b, Open-label Study of ABBV-383 Administered Subcutaneously in Subjects With Relapsed...
ABBV-383
View Trial
A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedul...
RADIATION + TALQUETAMAB FOR EXTRAMEDULLARY DISEASE
View Trial
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B
64CU-LLP2A-PET/CT
View Trial
A Phase 1b Trial of Teclistamab in Combination With Iberdomide for Relapsed/Refractory Multiple Myeloma
TECVAYLI
View Trial
Phase 1 Trial of SX-682, a CXCR 1/2 Inhibitor, in Combination With Standard of Care Treatment in Patients W...
SX-682
View Trial
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With ...
HIGH THROUGHPUT DRUG SENSITIVITY AND GENOMICS
View Trial
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
CHEMOSENSITIVITY STUDY
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
TISSUE BANKING
View Trial
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...
MEDULLA
View Trial
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab
DIGITAL HEALTH COACHING
View Trial
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MR...
HEME-20
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
NON-CHEMOTHERAPEUTIC INTERVENTIONS
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS
View Trial
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Sym...
AMBIENT LIGHT
View Trial
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...
ASH RESEARCH COLLABORATIVE DATA HUB
View Trial
The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...
REIKI
View Trial
The Prospective Collection, Storage and Reporting of Data on Patients
PATIENT REGISTRY: UNDERGOING STEM CELL TRANSPLANT
View Trial
An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients Wit...
APP SICP
View Trial
Tissue Procurement For Hematolymphoid Conditions
TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION
View Trial
A Randomized Pilot Study of Yoga Intervention in Patients With Multiple Myeloma on Active Therapy
WEEKLY YOGA
View Trial
Randomized Controlled Trial of a Psychosocial Mobile Application (THRIVE-M) for Patients Living With Multip...
THRIVE-M
View Trial
Sleep Apnea in Patients With MGUS and Multiple Myeloma
SLEEP APNEA
View Trial
Testing Two Implementation Strategies in Collecting ePRO Among Multiple Myeloma Patients
EPRO4MM
View Trial
Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Diso...
IDENTIFYING BARRIERS TO CELLULAR THERAPY
View Trial
Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For ...
EXERCISE PREHABILITATION
View Trial
The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A ...
IMPACT OF NON-PROFIT ON PATIENT OUTCOMES & CARE
View Trial
Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Tra...
PROACTIVE
View Trial
Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transpl...
CHAPLAIN-DELIVERED MEDITATION
View Trial
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
WU-PE-CGS
View Trial
Pilot Trial of Homebound Stem Cell Transplantation
HOMEBOUND STEM CELL TRANSPLANT
View Trial
Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Trans...
MUSCLE STIMULATION DURING STEM CELL TRANSPLANT
View Trial
Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cel...
PREHABILITATION FEASIBILITY
View Trial
Cancer Moonshot Biobank Research Protocol
CANCER MOONSHOT BIOBANK
View Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
GENETIC STUDIES
View Trial
Cancer Sequencing Guided Personalized and Precision Medicine Platform in Multiple Myeloma
PRECISION MEDICINE STUDY
View Trial
Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma
BIOMARKER FOR INFECTION RISK
View Trial
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
CARE-HEME
View Trial
A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Dive...
PREBIOTICS AFTER AUTOLOGOUS STEM CELL TRANSPLANT
View Trial
Prospective, Digitized Dietary Intake Monitoring in Individuals Undergoing Cancer Therapy
DIETARY INTAKE MONITORING
View Trial
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS
View Trial
An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
MOLECULAR PROFILING
View Trial
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogen...
TREATMENT EXPERIENCE OF PATIENTS
View Trial
Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
HEME HOSPICE - HOME TRANSFUSION PROGRAM
View Trial
Implementing a Plant-Based Whole-Foods Meal Delivery Service for Patients Undergoing Autologous Hematopoiet...
PLANT-BASED WHOLE-FOODS MEAL DELIVERY
View Trial
Smoldering Myeloma

The following is a listing of clinical trials for patients with Smoldering Myeloma.

Verified
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
IBERDOMIDE
View Trial
Verified
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
Verified
PTSD Mobile App for Cancer Survivors
PTSD MOBILE APP
View Trial
Verified
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
View Trial
Verified
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
View Trial
Verified
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Mult...
NUTRIVENTION3
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering ...
DETER-SMM
View Trial
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate...
CURCUMIN AND PIPERINE
View Trial
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
IMMUNO-PRISM
View Trial
DARA RVD For High Risk SMM
PRISM
View Trial
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
View Trial
CAR- PRISM (PRecision Intervention Smoldering Myeloma)
CAR-PRISM
View Trial
Teclistamab or Talquetamab in Combination With Daratumumab SC for High-Risk Smoldering Myeloma: A Clinical ...
REVIVE
View Trial
Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopat...
LINKER-MGUS1
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precurso...
TRANSFORMM
View Trial
Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
ORIGIN STUDY
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
TISSUE BANKING
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
NON-CHEMOTHERAPEUTIC INTERVENTIONS
View Trial
PROFAST Intervention in Precursor Multiple Myeloma
PROFAST
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS
View Trial
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The ...
MULTIPLE MYELOMA BIOREPOSITORY
View Trial
Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progre...
PCROWD
View Trial
Microbial Changes in Response to a Plant Based Diet and/or Supplements in SMM Patients: A National Multi-Ar...
SUPPLEMENTS OR PLANT-BASED DIET FOR SMM PATIENTS
View Trial
Sleep Apnea in Patients With MGUS and Multiple Myeloma
SLEEP APNEA
View Trial
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
SPOTLIGHT
View Trial
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
AMYLOIDOSIS SCREENING
View Trial
Monoclonal Gammopathy of Undetermined Significance (MGUS)

The following is a listing of clinical trials for patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).

Verified
Rifaximin in Patients With Monoclonal Gammopathy
RIFAXIMIN
View Trial
Verified
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
View Trial
Verified
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
View Trial
Verified
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Mult...
NUTRIVENTION3
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate...
CURCUMIN AND PIPERINE
View Trial
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
View Trial
Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopat...
LINKER-MGUS1
View Trial
Phase IIa Study to Evaluate Daratumumab for Polyneuropathy Associated With MGUS
DARA-MGUS
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precurso...
TRANSFORMM
View Trial
Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
ORIGIN STUDY
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
TISSUE BANKING
View Trial
PROFAST Intervention in Precursor Multiple Myeloma
PROFAST
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS
View Trial
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The ...
MULTIPLE MYELOMA BIOREPOSITORY
View Trial
Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progre...
PCROWD
View Trial
Sleep Apnea in Patients With MGUS and Multiple Myeloma
SLEEP APNEA
View Trial